These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29895574)

  • 1. Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile.
    Querfeld C; Leung S; Myskowski PL; Curran SA; Goldman DA; Heller G; Wu X; Kil SH; Sharma S; Finn KJ; Horwitz S; Moskowitz A; Mehrara B; Rosen ST; Halpern AC; Young JW
    Cancer Immunol Res; 2018 Aug; 6(8):900-909. PubMed ID: 29895574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors.
    Gaydosik AM; Tabib T; Geskin LJ; Bayan CA; Conway JF; Lafyatis R; Fuschiotti P
    Clin Cancer Res; 2019 Jul; 25(14):4443-4454. PubMed ID: 31010835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.
    Berger CL; Tigelaar R; Cohen J; Mariwalla K; Trinh J; Wang N; Edelson RL
    Blood; 2005 Feb; 105(4):1640-7. PubMed ID: 15514008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
    Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F
    Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma.
    Schlapbach C; Ochsenbein A; Kaelin U; Hassan AS; Hunger RE; Yawalkar N
    J Am Acad Dermatol; 2010 Jun; 62(6):995-1004. PubMed ID: 20466174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.
    Clark RA; Shackelton JB; Watanabe R; Calarese A; Yamanaka K; Campbell JJ; Teague JE; Kuo HP; Hijnen D; Kupper TS
    Blood; 2011 Feb; 117(6):1966-76. PubMed ID: 21148332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-dependent expression of CD7, CD45RO, CD45RA and CD25 on CD4-positive peripheral blood T-lymphocytes in cutaneous T-cell lymphoma.
    Jakob T; Neuber K; Altenhoff J; Kowalzick L; Ring J
    Acta Derm Venereol; 1996 Jan; 76(1):34-6. PubMed ID: 8721488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases.
    Aung PP; Climent F; Muzzafar T; Curry JL; Patel KP; Servitje O; Prieto VG; Duvic M; Jaffe ES; Torres-Cabala CA
    J Cutan Pathol; 2014 Jan; 41(1):51-7. PubMed ID: 24151865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of a CD8alphaalpha+ CD4- tumour T-cell clone with cytotoxic activity from a CD4+ CD8- cutaneous T-cell lymphoma.
    Nikolova M; Echchakir H; Wechsler J; Boumsell L; Bensussan A; Bagot M
    Br J Dermatol; 2003 Jan; 148(1):24-9. PubMed ID: 12534590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-8 immunoreactivity in epidermis of cutaneous T-cell lymphoma patients.
    Wismer JM; McKenzie RC; Sauder DN
    Lymphokine Cytokine Res; 1994 Feb; 13(1):21-7. PubMed ID: 8186321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell-based immunotherapy.
    Thumann P; Lüftl M; Moc I; Bagot M; Bensussan A; Schuler G; Jenne L
    Br J Dermatol; 2003 Dec; 149(6):1128-42. PubMed ID: 14674889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
    Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome.
    Shin J; Monti S; Aires DJ; Duvic M; Golub T; Jones DA; Kupper TS
    Blood; 2007 Oct; 110(8):3015-27. PubMed ID: 17638852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1 and inducible T-cell co-stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcome.
    Di Raimondo C; Rubio-Gonzalez B; Palmer J; Weisenburger DD; Zain J; Wu X; Han Z; Rosen ST; Song JY; Querfeld C
    Br J Dermatol; 2022 Aug; 187(2):234-243. PubMed ID: 35194801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
    Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
    Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.